Pharmaceuticals, Biotechnology and Life Sciences
— Partnership combines ArsenalBio’s programmable cell therapy approach with Bristol Myers Squibb’s expertise in cell therapy and oncology drug development…
– Vutrisiran Met Primary and All Secondary Endpoints at 9 Months, with Statistically Significant Improvements in Progression of Neuropathy, Quality…
– Vutrisiran Met Primary and All Secondary Endpoints at 9 Months, with Statistically Significant Improvements in Progression of Neuropathy, Quality…
— First and only prescription therapy approved specifically for short-term treatment of the signs and symptoms of dry eye disease…
Proceeds will enable advancement and acceleration of the Company’s transformative drug discovery programs derived from digital search of the fungal…
– Product candidate taladegib inhibits chronic Hedgehog signaling pathway, an underlying mechanism behind Idiopathic Pulmonary Fibrosis (IPF) – Two Phase…
– First patients with COVID-19 enrolled in the REVIVAL Phase III study – COVID-19 patients with sepsis-associated acute kidney injury…
License to utilise Avacta’s pre|CISION FAP-sensitive activation platform for radiopharmaceuticals CAMBRIDGE, England & WETHERBY, England–(BUSINESS WIRE)–Avacta Group plc (AIM: AVCT),…
BGV now one of the largest biotech investors in early stage ventures and company creation in Europe BGV IV includes…
NORTH AUGUSTA, S.C.–(BUSINESS WIRE)–#API–AmbioPharm Inc., a worldwide leader in peptide API CDMO services, has recently opened its new Shanghai campus.…